Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Expert Rev Neurother. 2010 Jun;10(6):943–959. doi: 10.1586/ern.10.57

Table 2.

Risk of major congenital malformation and congenital heart defects associated with phenobarbital monotherapy.

Study CM (n) Cardiac malformations % of cardiac malformations (cases/n) Ref.
Samrén (1999) 3 2 66.67 [12]
Holmes (2001) 3 2 66.67 [10]
Holmes (2004) 5 3 60.00 [29]
Thomas (2008) NA Three out of 43 monotherapy exposures [18]

One cardiac defect was associated with an aberrant chromosome.

CM: Congenital malformation; NA: Not available.